Selected research
Industry Research
Morphine Industry Research Report 2026
Market perspective
The global Morphine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Morphine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Morphine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Morphine include Sun Pharmaceutical Industries, Qinghai Pharmaceutical, Northeast Pharmaceutical Group, Sanofi Winthrop Industrie, Purdue Pharma, Mallinckrodt Pharmaceuticals, Macfarlan Smith and Alcaliber, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Morphine market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Morphine Market by Company
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
Sanofi Winthrop Industrie
Purdue Pharma
Mallinckrodt Pharmaceuticals
Macfarlan Smith
Alcaliber
Morphine Segment by Type
Injection
Oral Tablets
Capsule
Others
Morphine Segment by Application
Diarrhea Suppressant
Cough Suppressant
Anesthesia
Morphine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morphine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Morphine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morphine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Morphine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Morphine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Morphine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Oral Tablets
- Capsule
- Others
Applications
- Diarrhea Suppressant
- Cough Suppressant
- Anesthesia
Companies covered
- Sun Pharmaceutical Industries
- Qinghai Pharmaceutical
- Northeast Pharmaceutical Group
- Sanofi Winthrop Industrie
- Purdue Pharma
- Mallinckrodt Pharmaceuticals
- Macfarlan Smith
- Alcaliber
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Morphine Market Size (2021-2032)
- 2.2.2 Global Morphine Sales (2021-2032)
- 2.2.3 Global Morphine Market Average Price (2021-2032)
- 2.3 Morphine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Oral Tablets
- 2.3.4 Capsule
- 2.3.5 Others
- 2.4 Morphine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diarrhea Suppressant
- 2.4.3 Cough Suppressant
- 2.4.4 Anesthesia
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Morphine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Morphine Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Morphine Revenue of Manufacturers (2021-2026)
- 3.4 Global Morphine Average Price by Manufacturers (2021-2026)
- 3.5 Global Morphine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Morphine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Morphine, Product Type & Application
- 3.8 Global Manufacturers of Morphine, Established Date
- 3.9 Global Morphine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical Industries
- 4.1.1 Sun Pharmaceutical Industries Company Information
- 4.1.2 Sun Pharmaceutical Industries Business Overview
- 4.1.3 Sun Pharmaceutical Industries Morphine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Industries Morphine Product Portfolio
- 4.1.5 Sun Pharmaceutical Industries Recent Developments
- 4.2 Qinghai Pharmaceutical
- 4.2.1 Qinghai Pharmaceutical Company Information
- 4.2.2 Qinghai Pharmaceutical Business Overview
- 4.2.3 Qinghai Pharmaceutical Morphine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qinghai Pharmaceutical Morphine Product Portfolio
- 4.2.5 Qinghai Pharmaceutical Recent Developments
- 4.3 Northeast Pharmaceutical Group
- 4.3.1 Northeast Pharmaceutical Group Company Information
- 4.3.2 Northeast Pharmaceutical Group Business Overview
- 4.3.3 Northeast Pharmaceutical Group Morphine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Northeast Pharmaceutical Group Morphine Product Portfolio
- 4.3.5 Northeast Pharmaceutical Group Recent Developments
- 4.4 Sanofi Winthrop Industrie
- 4.4.1 Sanofi Winthrop Industrie Company Information
- 4.4.2 Sanofi Winthrop Industrie Business Overview
- 4.4.3 Sanofi Winthrop Industrie Morphine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi Winthrop Industrie Morphine Product Portfolio
- 4.4.5 Sanofi Winthrop Industrie Recent Developments
- 4.5 Purdue Pharma
- 4.5.1 Purdue Pharma Company Information
- 4.5.2 Purdue Pharma Business Overview
- 4.5.3 Purdue Pharma Morphine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Purdue Pharma Morphine Product Portfolio
- 4.5.5 Purdue Pharma Recent Developments
- 4.6 Mallinckrodt Pharmaceuticals
- 4.6.1 Mallinckrodt Pharmaceuticals Company Information
- 4.6.2 Mallinckrodt Pharmaceuticals Business Overview
- 4.6.3 Mallinckrodt Pharmaceuticals Morphine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mallinckrodt Pharmaceuticals Morphine Product Portfolio
- 4.6.5 Mallinckrodt Pharmaceuticals Recent Developments
- 4.7 Macfarlan Smith
- 4.7.1 Macfarlan Smith Company Information
- 4.7.2 Macfarlan Smith Business Overview
- 4.7.3 Macfarlan Smith Morphine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Macfarlan Smith Morphine Product Portfolio
- 4.7.5 Macfarlan Smith Recent Developments
- 4.8 Alcaliber
- 4.8.1 Alcaliber Company Information
- 4.8.2 Alcaliber Business Overview
- 4.8.3 Alcaliber Morphine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Alcaliber Morphine Product Portfolio
- 4.8.5 Alcaliber Recent Developments
5 Global Morphine Market Scenario by Region
- 5.1 Global Morphine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Morphine Sales by Region: 2021-2032
- 5.2.1 Global Morphine Sales by Region: 2021-2026
- 5.2.2 Global Morphine Sales by Region: 2027-2032
- 5.3 Global Morphine Revenue by Region: 2021-2032
- 5.3.1 Global Morphine Revenue by Region: 2021-2026
- 5.3.2 Global Morphine Revenue by Region: 2027-2032
- 5.4 North America Morphine Market Facts & Figures by Country
- 5.4.1 North America Morphine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Morphine Sales by Country (2021-2032)
- 5.4.3 North America Morphine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Morphine Market Facts & Figures by Country
- 5.5.1 Europe Morphine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Morphine Sales by Country (2021-2032)
- 5.5.3 Europe Morphine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Morphine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Morphine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Morphine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Morphine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Morphine Market Facts & Figures by Country
- 5.7.1 South America Morphine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Morphine Sales by Country (2021-2032)
- 5.7.3 South America Morphine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Morphine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Morphine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Morphine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Morphine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Morphine Sales by Type (2021-2032)
- 6.1.1 Global Morphine Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Morphine Sales Market Share by Type (2021-2032)
- 6.2 Global Morphine Revenue by Type (2021-2032)
- 6.2.1 Global Morphine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Morphine Revenue Market Share by Type (2021-2032)
- 6.3 Global Morphine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Morphine Sales by Application (2021-2032)
- 7.1.1 Global Morphine Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Morphine Sales Market Share by Application (2021-2032)
- 7.2 Global Morphine Revenue by Application (2021-2032)
- 7.2.1 Global Morphine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Morphine Revenue Market Share by Application (2021-2032)
- 7.3 Global Morphine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Morphine Value Chain Analysis
- 8.1.1 Morphine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Morphine Production Mode & Process
- 8.2 Morphine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Morphine Distributors
- 8.2.3 Morphine Customers
9 Global Morphine Analyzing Market Dynamics
- 9.1 Morphine Industry Trends
- 9.2 Morphine Industry Drivers
- 9.3 Morphine Industry Opportunities and Challenges
- 9.4 Morphine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst